CCEL Q4 2022 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q4 2022 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M+6.1% YoY

Gross Profit

$6M72.5% margin

Operating Income

$581,6777.5% margin

Net Income

$837,82210.8% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+1.1%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$150,904

Balance Sheet

Total Assets

$65M

Total Liabilities

$66M

Stockholders' Equity

-$2M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$7M	+6.1%
Gross Profit	$6M	$5M	+12.1%
Operating Income	$581,677	-$823,545	+170.6%
Net Income	$837,822	-$637,192	+231.5%

Revenue Segments

Processing And Storage Fees

$8M98%

Public Banking

$124,2212%

Product

$28,4000%